The downgrade means Anthem stock is expected to perform in line with its average return of stock, rather than outperform its average return of stock as projected.
Indianapolis-based Anthem — which has a 52-week low of $115.63 and a 52-week high of $149.50 — opened at $121.09 Monday.
More articles about payer issues:
Update: Insurers weigh in on civil rights allegations over HIV drug coverage
11.7 million uninsured eligible for Medicaid, tax credits under ACA
Regulators approve double-digit health plan rate hikes for Illinois
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
